New Brain Tumor Clinical Trials: July- December 2022 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for patients with a primary brain tumor*. Follow the hyperlink above to learn more about […] January 20, 2023
Guest Blog: A Patient and Philosopher Goes to the Biggest Brain Tumor Research Conference of the Year Glioblastoma patient and NBTS Board member, Adam Hayden, reflects on attending the 2022 Society for Neuro-Oncology Annual Meeting The Philosopher-Patient I was diagnosed with glioblastoma in the final year of my graduate studies, ironically specializing in the Philosophy of Science. Ironic because what could be more absurd than a philosopher with brain cancer?! The brain […] December 16, 2022
Breakthroughs Ahead: Holly Gibbons Three months after delivering a baby boy, Holly returned to the same hospital where they discovered a brain tumor — grade 3 anaplastic astrocytoma. This 2016 diagnosis led her family to join National Brain Tumor Society events like Race for Hope DC and Head to the Hill to fundraise and advocate for increased funding for […] December 12, 2022
Breakthroughs Ahead: Liz Salmi National Brain Tumor Society board member Liz Salmi and her husband Brett have been living with her grade 2 astrocytoma diagnosis for 15 years. We’re so grateful for her service and for allowing us to share her story with our community. Watch Liz’s video and learn how their experiences have led them to champion the […] December 5, 2022
Caring for the Caregiver: 9 Ways You Can Support a Care Partner of a Patient with a Brain Tumor An estimated 700,000 Americans are living with a primary brain tumor in 2022. For each patient with a brain tumor, at least one loved one may provide support as a care partner. Unpaid caregivers have a plethora of responsibilities to help care for a family member or friend throughout their brain tumor experience, in addition […] November 23, 2022